{"id":"https://openalex.org/W2169738404","doi":"https://doi.org/10.2174/1871526510909010023","title":"Tetracyclines and Prion Infectivity","display_name":"Tetracyclines and Prion Infectivity","alternate_titles":[],"publication_year":2009,"publication_date":"2009-02-01","ids":{"openalex":"https://openalex.org/W2169738404","doi":"https://doi.org/10.2174/1871526510909010023","mag":"2169738404","pmid":"https://pubmed.ncbi.nlm.nih.gov/19200012"},"language":"en","primary_location":{"id":"doi:10.2174/1871526510909010023","doi":"https://doi.org/10.2174/1871526510909010023","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871526510909010023","pdf_url":null,"source":{"id":"https://openalex.org/S2765027702","display_name":"Infectious Disorders - Drug Targets","issn_l":"1871-5265","issn":["1871-5265","2212-3989"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Disorders - Drug Targets","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2169738404"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084544899","display_name":"Gianluigi Forloni","orcid":"https://orcid.org/0000-0001-5374-3914","observed_orcids":["https://orcid.org/0000-0001-5374-3914"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gianluigi Forloni","raw_affiliation_strings":["Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy. forloni@marionegri.it","Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy. forloni@marionegri.it","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020722865","display_name":"Mario Salmona","orcid":"https://orcid.org/0000-0002-9098-9873","observed_orcids":["https://orcid.org/0000-0002-9098-9873"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mario Salmona","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri;","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103560918","display_name":"Gabriella Marcon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129043915","display_name":"University of Udine","ror":"https://ror.org/05ht0mh31","country_code":"IT","type":"education","lineage":["https://openalex.org/I129043915"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriella Marcon","raw_affiliation_strings":["University of Udine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Udine","institution_ids":["https://openalex.org/I129043915"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004166000","display_name":"Fabrizio Tagliavini","orcid":"https://orcid.org/0000-0003-1039-7315","observed_orcids":["https://orcid.org/0000-0003-1039-7315"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fabrizio Tagliavini","raw_affiliation_strings":["Department of Neuroscience, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Via G. La Masa 19, 20056 Milano, Italy.,Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Via G. La Masa 19, 20056 Milano, Italy.,Italy","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4525,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.79413496,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"9","issue":"1","first_page":"23","last_page":"30"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11335","display_name":"Prion Diseases and Protein Misfolding","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11335","display_name":"Prion Diseases and Protein Misfolding","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tetracycline","display_name":"tetracycline","score":1.0},{"id":"https://openalex.org/keywords/doxycycline","display_name":"doxycycline","score":0.902999997138977},{"id":"https://openalex.org/keywords/minocycline","display_name":"minocycline","score":1.0},{"id":"https://openalex.org/keywords/prion-infectivity","display_name":"prion infectivity","score":0.7879999876022339},{"id":"https://openalex.org/keywords/prion-disease","display_name":"prion disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/scrapie","display_name":"scrapie","score":0.9229999780654907},{"id":"https://openalex.org/keywords/proteinase-k-resistance","display_name":"proteinase K resistance","score":0.8169999718666077},{"id":"https://openalex.org/keywords/protein-misfolding","display_name":"protein misfolding","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C2776735649","wikidata":"https://www.wikidata.org/wiki/Q170102","display_name":"Scrapie","level":4,"score":0.9170738458633423},{"id":"https://openalex.org/C106358424","wikidata":"https://www.wikidata.org/wiki/Q1662346","display_name":"Infectivity","level":3,"score":0.8395484089851379},{"id":"https://openalex.org/C2778275353","wikidata":"https://www.wikidata.org/wiki/Q415336","display_name":"Minocycline","level":3,"score":0.7521790266036987},{"id":"https://openalex.org/C2777179404","wikidata":"https://www.wikidata.org/wiki/Q422442","display_name":"Doxycycline","level":3,"score":0.7505066394805908},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5828873515129089},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5681984424591064},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5079146027565002},{"id":"https://openalex.org/C2778471508","wikidata":"https://www.wikidata.org/wiki/Q425310","display_name":"Proteinase K","level":3,"score":0.4770697355270386},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4748656749725342},{"id":"https://openalex.org/C2776797465","wikidata":"https://www.wikidata.org/wiki/Q703961","display_name":"Transmissible spongiform encephalopathy","level":5,"score":0.46486979722976685},{"id":"https://openalex.org/C27523624","wikidata":"https://www.wikidata.org/wiki/Q14860849","display_name":"Fibril","level":2,"score":0.45629146695137024},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.4517006278038025},{"id":"https://openalex.org/C3019804061","wikidata":"https://www.wikidata.org/wiki/Q14881255","display_name":"Prion protein","level":3,"score":0.42300501465797424},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4058067500591278},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.33250343799591064},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2884455919265747},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28518879413604736},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.26077574491500854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.15618464350700378},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.12323421239852905},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12138739228248596},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011328","descriptor_name":"Prions","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011328","descriptor_name":"Prions","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011328","descriptor_name":"Prions","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":true},{"descriptor_ui":"D011328","descriptor_name":"Prions","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011500","descriptor_name":"Protein Synthesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011500","descriptor_name":"Protein Synthesis Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D012608","descriptor_name":"Scrapie","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013050","descriptor_name":"Spectrometry, Fluorescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013754","descriptor_name":"Tetracyclines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013754","descriptor_name":"Tetracyclines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018620","descriptor_name":"PrPSc Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018620","descriptor_name":"PrPSc Proteins","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D019286","descriptor_name":"Endopeptidase K","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.2174/1871526510909010023","doi":"https://doi.org/10.2174/1871526510909010023","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1871526510909010023","pdf_url":null,"source":{"id":"https://openalex.org/S2765027702","display_name":"Infectious Disorders - Drug Targets","issn_l":"1871-5265","issn":["1871-5265","2212-3989"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious Disorders - Drug Targets","raw_type":"journal-article"},{"id":"pmid:19200012","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19200012","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Infectious disorders drug targets","raw_type":"Journal Article"},{"id":"pmh:oai:air.uniud.it:11390/727041","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11390/727041","pdf_url":null,"source":{"id":"https://openalex.org/S4306401163","display_name":"Institutional Research Information System (University of Udine)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I129043915","host_organization_name":"University of Udine","host_organization_lineage":["https://openalex.org/I129043915"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:arts.units.it:11368/2930687","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11368/2930687","pdf_url":null,"source":{"id":"https://openalex.org/S4306400480","display_name":"ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142444530","host_organization_name":"University of Trieste","host_organization_lineage":["https://openalex.org/I142444530"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1974384579","https://openalex.org/W1973842453","https://openalex.org/W2615271989","https://openalex.org/W2112937571","https://openalex.org/W2360471542","https://openalex.org/W1978228537","https://openalex.org/W2626181570","https://openalex.org/W1969868345","https://openalex.org/W2132993221","https://openalex.org/W1963855152"],"abstract_inverted_index":{"In":[0],"the":[1,8,19,23,29,32,72,110,132,187,198],"last":[2],"decade":[3],"information":[4],"has":[5],"accumulated":[6],"on":[7],"potential":[9],"anti-prion":[10],"activity":[11,168],"of":[12,31,112,147,169,176,189,200],"polycyclic":[13],"compounds.":[14],"Initially":[15],"we":[16,37],"showed":[17],"that":[18,43],"antitumoral":[20],"idodoxorubicin":[21],"reduced":[22],"infectivity":[24],"in":[25,51,66,75,153,173,195,197,204],"experimental":[26,154],"scrapie.":[27],"On":[28],"basis":[30],"chemical":[33],"homology":[34],"with":[35,87,92,126,136,181],"anthracyclines,":[36],"rapidly":[38],"moved":[39],"to":[40,118],"tetracyclines,":[41,55],"compounds":[42],"are":[44,82],"safer":[45],"and":[46,58,77,80,107,130,156,178],"widely":[47],"used":[48],"as":[49,62,191],"antibiotics":[50],"clinical":[52],"practice.":[53],"The":[54,166],"essentially":[56],"doxycycline":[57,151],"minocycline,":[59],"were":[60],"characterized":[61],"a":[63,145,192],"therapeutical":[64],"tool":[65,194],"transmissible":[67],"spongiform":[68],"encephalopathies":[69],"(TSE)":[70],"through":[71],"cell-free":[73],"condition,":[74],"cellular":[76],"animal":[78],"models":[79],"they":[81,108],"now":[83],"being":[84],"investigated":[85],"clinically":[86],"this":[88],"indication.":[89],"Tetracyclines":[90,123],"interact":[91,125],"aggregates":[93],"obtained":[94,203],"by":[95,120,144,150],"synthetic":[96],"PrP":[97,101],"peptides":[98],"or":[99,163],"pathological":[100],"(PrPsc)":[102],"extracted":[103],"from":[104],"TSE":[105,196],"brains,":[106],"destabilize":[109],"structure":[111],"amyloid":[113],"fibrils,":[114],"reducing":[115],"their":[116],"resistance":[117],"digestion":[119],"proteinase":[121],"K.":[122],"also":[124],"peptide":[127],"oligomeric":[128],"structures":[129],"inhibit":[131],"protein":[133],"misfolding":[134],"associated":[135],"PrPsc":[137],"formation.":[138],"These":[139],"activities":[140],"have":[141],"been":[142],"accompanied":[143],"reduction":[146],"infectivity,":[148],"verified":[149],"treatment":[152],"scrapie,":[155],"some":[157],"curative":[158],"effects":[159],"after":[160],"either":[161],"peripheral":[162,177],"intracerebral":[164],"infection.":[165],"anti-amyloidogenic":[167],"tetracyclines":[170,190],"was":[171],"tested":[172],"other":[174],"forms":[175],"central":[179],"amyloidosis,":[180],"interesting":[182],"results.":[183],"This":[184],"article":[185],"analyzes":[186],"development":[188],"therapeutic":[193],"light":[199],"recent":[201],"results":[202],"our":[205],"laboratories.":[206]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2169738404","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":7},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
